National Peanut Board Company Profile

19:58 EDT 23rd October 2019 | BioPortfolio

News Articles [1177 Associated News Articles listed on BioPortfolio]

Peanut Patch Linked to Increased Responder Rate in Children

TUESDAY, March 5, 2019 -- For peanut-allergic children, use of epicutaneous immunotherapy with a peanut patch is associated with a statistically significant increase in the percentage of responders (m...

Peanut Allergen Inhibitor Developed Using Nanoparticles

Preventing the torrent of signaling molecules that are released during an adverse peanut reaction could not only prove to be helpful to many of the estimated 4.2 million children living with this alle...

FDA Doesn’t Shell Peanut Allergy Drug Pre-Hearing, Aimmune Shares Climb

Peanut allergy sufferers know they need to stay away from certain foods that can put them in danger. But what about accidental exposure? Even trace amounts of peanut protein in their food or someone e...

[Articles] Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study

Our study suggests that peanut OIT could desensitise individuals with peanut allergy to 4000 mg peanut protein but discontinuation, or even reduction to 300 mg daily, could increase the likelihood of ...

DBV Technologies announces FDA acceptance of BLA filing for Viaskin Peanut to treat peanut allergy

Viaskin Peanut is the Company’s lead product candidate designed to potentially reduce the risk of life-threatening allergic reactions due to accidental exposure to peanuts. A non-invasive, once-dail...

BLA for peanut allergy skin patch for children accepted by FDA

DBV Technologies' biologics license application for its peanut allergy treatment Viaskin Peanut has been accepted by the FDA  -More- 

Mutagenesis of FAD2 genes in peanut with CRISPR/Cas9 based gene editing

Increasing the content of oleic acid in peanut seeds is one of the major goals in peanut breeding due to consumer and industry benefits, such as anti-oxidation and long shelf-life. Homeologous ahFAD2A...

Is Peanut Allergy 'Immunotherapy' Causing More Harm Than Good?

THURSDAY, April 25, 2019 -- The idea behind immunotherapy for peanut allergy is appealing in its simplicity: Ask a patient to eat tiny amounts of peanut every day, and over time their immune system wi...

Drugs and Medications [85 Associated Drugs and Medications listed on BioPortfolio]

Ph7 gel mint [pascal company, inc.]


Bal in oil ampulesdimercaprol injection, usp [taylor pharmaceuticals]


Bal [akorn, inc.]


60 second taste marshmallow [pascal company, inc.]

60 Second Taste Marshmallow

Fluocinolone acetonide 0.01% [seton pharmaceuticals]

Fluocinolone Acetonide 0.01% OilEar Drops

PubMed Articles [1028 Associated PubMed Articles listed on BioPortfolio]

Implementation of Early Peanut Introduction Guidelines: It Takes a Village.

A landmark study showed that early peanut introduction in high-risk infants, defined as infants with moderate to severe atopic dermatitis or egg allergy, reduced the risk of developing peanut allergy....

Earlier ingestion of peanut following changes to infant feeding guidelines: The EarlyNuts Study.

Randomized controlled trials demonstrate that timely introduction of peanut to infants reduces the risk of peanut allergy. However, much debate remains regarding how to best achieve earlier peanut int...

Variables associated with successful performance on the National Board of Chiropractic Examiners Part IV examination.

The objectives of this study were to (1) identify factors predictive of performance on the National Board of Chiropractic Examiners Part IV exam and (2) investigate correlations between the scores obt...

Epicutaneous Exposure to Peanut Oil Induces Systemic and Pulmonary Allergic Reaction in Mice.

The prevalence of peanut allergy (PA) is constantly on the rise. Atopic dermatitis (AD) is a major risk factor for developing food allergy. Some bath oils and skin creams used for treating AD contain ...

Peanut protein-polyphenol aggregate complexation suppresses allergic sensitization to peanut by reducing peanut-specific IgE in C3H/HeJ mice.

Peanut allergy is usually lifelong and accidental exposure impose formidable risk. The aim of this study was to assess the capacity of peanut proteins complexed to polyphenol extracts to reduce allerg...

Clinical Trials [1806 Associated Clinical Trials listed on BioPortfolio]

Peanut Oral Immunotherapy

This is a study in which increasing amounts of peanut flour are given to the children who are peanut allergic to desensitize them to peanut. The hypothesis is that the peanut allergic pati...

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age

The study aims to assess the safety and efficacy of Viaskin Peanut to induce desensitization to peanut in peanut-allergic children 1 to 3 years of age after a 12-month treatment by EPicuta...

Boiled Peanut Oral Immunotherapy

Prospective Phase 1 clinical trial providing proof of concept data on boiled peanut oral immunotherapy (OIT) for the treatment of peanut allergy in children. The investigators hypothesize ...

Early Life Origins of the Food Allergy Epidemic

The purpose of this study is to determine if avoidance of peanut by children with positive allergy testing to peanut in the first 5 years of life increases the likelihood of developing a p...

Early Peanut Introduction: Translation to Clinical Practice

The recent finding that early introduction of peanut can prevent ~70-90% of peanut allergy is a major step towards prevention of food allergy. However, because that finding was from a clin...

Companies [1755 Associated Companies listed on BioPortfolio]

National Peanut Board

National Advisory Board

The National Advisory Board on Improving Health Care Services for Seniors and People with Disabilities was created by AMERIGROUP Corporation in 2007. Drawing from a wide range of distinguished communi...

American Egg Board

AEB is the U.S. egg producer's link to the consumer in communicating the value of The incredible edible egg(TM) and is funded from a national legislative checkoff on all egg production from companies ...

The Peanut Institute

Foro Argentino de Biotecnología

The Foro Argentino de Biotecnología (FAB) was established in November 1986 as a non-profit-making foundation on the initiative of three pioneer enterprises in the biotechnology area, under the honora...

More Information about "National Peanut Board" on BioPortfolio

We have published hundreds of National Peanut Board news stories on BioPortfolio along with dozens of National Peanut Board Clinical Trials and PubMed Articles about National Peanut Board for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of National Peanut Board Companies in our database. You can also find out about relevant National Peanut Board Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record